AAAAAA
Results: 1-25/93
Authors:
HACKE W
LEES KR
TIMMERHUIS T
HAAN J
HANTSON L
HENNERICI M
DIENER HC
Citation: W. Hacke et al., CARDIOVASCULAR SAFETY OF LUBELUZOLE (PROSYNAP(R)) IN PATIENTS WITH ISCHEMIC STROKE, Cerebrovascular diseases, 8(5), 1998, pp. 247-254
Authors:
MUIR KW
HAMILTON SJC
LUNNON MW
HOBBIGER S
LEES KR
Citation: Kw. Muir et al., SAFETY AND TOLERABILITY OF 619C89 AFTER ACUTE STROKE, Cerebrovascular diseases, 8(1), 1998, pp. 31-37
Authors:
MURRAY L
SQUIRE IB
REID JL
LEES KR
Citation: L. Murray et al., DETERMINANTS OF THE BLOOD-PRESSURE RESPONSE TO THE FIRST DOSE OF ACE-INHIBITOR IN MILD-TO-MODERATE CONGESTIVE-HEART-FAILURE, British journal of clinical pharmacology, 45(6), 1998, pp. 559-566
Authors:
LEES KR
Citation: Kr. Lees, MULTIFACTORIAL APPROACH TO STROKE INVESTIGATION AND PREVENTION, Lancet, 352(9132), 1998, pp. 923-924
Authors:
LEES KR
Citation: Kr. Lees, IF I HAD A STROKE, Lancet, 352, 1998, pp. 28-30
Authors:
LEES KR
Citation: Kr. Lees, DOES NEUROPROTECTION IMPROVE STROKE OUTCOME, Lancet, 351(9114), 1998, pp. 1447-1448
Authors:
MUIR K
LEES KR
Citation: K. Muir et Kr. Lees, THROMBOLYTIC THERAPY FOR ACUTE ISCHEMIC STROKE (VOL 350, PG 1476, 1997), Lancet, 351(9099), 1998, pp. 376-376
Authors:
MCCARRON MO
MUIR KW
WEIR CJ
DYKER AG
BONE I
NICOLL JAR
LEES KR
Citation: Mo. Mccarron et al., THE APOLIPOPROTEIN-E EPSILON-4 ALLELE AND OUTCOME IN CEREBROVASCULAR-DISEASE, Stroke, 29(9), 1998, pp. 1882-1887
Authors:
MUIR KW
LEES KR
Citation: Kw. Muir et Kr. Lees, DOSE OPTIMIZATION OF INTRAVENOUS MAGNESIUM-SULFATE AFTER ACUTE STROKE, Stroke, 29(5), 1998, pp. 918-923
Authors:
GRATTON JA
SAUTER A
RUDIN M
LEES KR
MCCOLL J
REID JL
DOMINICZAK AF
MACRAE IM
Citation: Ja. Gratton et al., SUSCEPTIBILITY TO CEREBRAL INFARCTION IN THE STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RAT IS INHERITED AS A DOMINANT TRAIT, Stroke, 29(3), 1998, pp. 690-694
Authors:
DYKER AG
LEES KR
Citation: Ag. Dyker et Kr. Lees, DURATION OF NEUROPROTECTIVE TREATMENT FOR ISCHEMIC STROKE, Stroke, 29(2), 1998, pp. 535-542
Authors:
DYKER AG
LEES KR
Citation: Ag. Dyker et Kr. Lees, INFLUENCE OF CHOLESTEROL ON SURVIVAL AFTER STROKE - REPLY, BMJ. British medical journal, 315(7116), 1997, pp. 1159-1159
Authors:
DYKER AG
WEIR CJ
LEES KR
Citation: Ag. Dyker et al., INFLUENCE OF CHOLESTEROL ON SURVIVAL AFTER STROKE - RETROSPECTIVE STUDY, BMJ. British medical journal, 314(7094), 1997, pp. 1584-1588
Authors:
WEIR CJ
MURRAY GD
DYKER AG
LEES KR
Citation: Cj. Weir et al., IS HYPERGLYCEMIA AN INDEPENDENT PREDICTOR OF POOR OUTCOME AFTER ACUTESTROKE - RESULTS OF A LONG-TERM FOLLOW-UP-STUDY, BMJ. British medical journal, 314(7090), 1997, pp. 1303-1306
Authors:
MUIR KW
GROSSET DG
LEES KR
Citation: Kw. Muir et al., EFFECTS OF PROLONGED INFUSIONS OF THE NMDA ANTAGONIST APTIGANEL HYDROCHLORIDE (CNS-1102) IN NORMAL VOLUNTEERS, Clinical neuropharmacology, 20(4), 1997, pp. 311-321
Authors:
WEIR CJ
BOLSTER AA
TYTLER S
MURRAY GD
CORRIGALL RS
ADAMS FG
LEES KR
Citation: Cj. Weir et al., PROGNOSTIC VALUE OF SINGLE-PHOTON EMISSION TOMOGRAPHY IN ACUTE ISCHEMIC STROKE, European journal of nuclear medicine, 24(1), 1997, pp. 21-26
Authors:
MACKENZIE C
BEGG T
BRADY M
LEES KR
Citation: C. Mackenzie et al., THE EFFECTS ON VERBAL COMMUNICATION-SKILLS OF RIGHT-HEMISPHERE STROKEIN MIDDLE-AGE, Aphasiology, 11(10), 1997, pp. 929-945
Authors:
MUIR K
LEES KR
Citation: K. Muir et Kr. Lees, THROMBOLYTIC THERAPY FOR ACUTE ISCHEMIC STROKE, Lancet, 350(9089), 1997, pp. 1476-1477
Authors:
LEES KR
REID JL
Citation: Kr. Lees et Jl. Reid, ADVERSE EVENT WITH FIRST-DOSE PERINDOPRIL IN CONGESTIVE-HEART-FAILURE, Lancet, 350(9076), 1997, pp. 520-520
Authors:
BRADFORD APJ
KHAN SA
LEES KR
MCINNES GT
SEMPLE PF
Citation: Apj. Bradford et al., INTERPRETATION OF IST AND CAST STROKE TRIALS, Lancet, 350(9075), 1997, pp. 440-441
Authors:
DAVIS SM
ALBERS GW
DIENER HC
LEES KR
NORRIS J
Citation: Sm. Davis et al., TERMINATION OF ACUTE STROKE STUDIES INVOLVING SELFOTEL TREATMENT, Lancet, 349(9044), 1997, pp. 32-32
Authors:
DYKER AG
MUIR KW
LEES KR
Citation: Ag. Dyker et al., A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, DOSE-ESCALATION STUDYOF REMACEMIDE IN PATIENTS WITH ACUTE STROKE, Stroke, 28(1), 1997, pp. 5-5
Authors:
DYKER AG
LEES KR
PRESTON C
CAVEGGION E
Citation: Ag. Dyker et al., THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF GV150526A IN PATIENTS WITH ACUTE STROKE, Stroke, 28(1), 1997, pp. 6-6
Authors:
LEES KR
Citation: Kr. Lees, CERESTAT AND OTHER NMDA ANTAGONISTS IN ISCHEMIC STROKE, Neurology, 49(5), 1997, pp. 66-69
Authors:
SQUIRE IB
LEES KR
PRYSEPHILLIPS W
KERTESZ A
BAMFORD J
REID JL
LEBRUN LH
NORRIS JW
CASTLEDEN CM
DUKE R
SILVER F
COTE R
HACHINSKI R
BERGER L
HAMILTON SJC
VENABLES G
PERRY H
ANDERSON B
BATES D
Citation: Ib. Squire et al., THE EFFECTS OF LIFARIZINE IN ACUTE CEREBRAL INFARCTION - A PILOT SAFETY STUDY, Cerebrovascular diseases, 6(3), 1996, pp. 156-160